13F Filings History of Bellevue Group AG

Latest 13F report
Q3 2025 - 14 Nov 2025
Value $
$4,812,815,152
Signature - Title
Christoph Eisenring / Stefano Montalbano - Head Legal & Compliance / CFO
Location
Zurich
Summary
This page shows a list of all the recent 13F filings made by Bellevue Group AG. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Bellevue Group AG reported 148 stock holdings with total value $4,812,815,152 as of Q3 2025. Top holdings included IONS, ARGX, RVMD, NBIX, and ALNY.

Notify me when Bellevue Group AG files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 148 $4,812,815,152 +$302,348,061 -$534,655,857 -$232,307,796 IONS, ARGX, RVMD, NBIX, ALNY 13F-HR 14 Nov 2025, 16:58
Q2 2025 142 $4,537,171,430 +$321,318,711 -$429,792,946 -$108,474,235 ARGX, IONS, NBIX, ALNY, ABT 13F-HR 14 Aug 2025, 15:15
Q1 2025 148 $4,462,826,678 +$171,263,323 -$638,539,073 -$467,275,750 ARGX, IONS, SYK, ISRG, ALNY 13F-HR 14 May 2025, 16:11
Q4 2024 160 $5,194,972,231 +$158,665,803 -$823,076,351 -$664,410,548 ARGX, IONS, NBIX, ISRG, ITCI 13F-HR 14 Feb 2025, 16:06
Q3 2024 162 $6,172,409,459 +$236,023,530 -$504,826,367 -$268,802,837 ARGX, IONS, VRTX, ISRG, ALNY 13F-HR 14 Nov 2024, 17:16
Q2 2024 166 $6,154,328,892 +$427,667,383 -$706,223,947 -$278,556,564 IONS, ARGX, VRTX, NBIX, ISRG 13F-HR 14 Aug 2024, 14:04
Q1 2024 169 $6,556,865,621 +$354,195,341 -$587,546,488 -$233,351,147 IONS, ARGX, NBIX, VRTX, ISRG 13F-HR 15 May 2024, 14:57
Q4 2023 161 $6,537,470,217 +$440,998,889 -$807,010,379 -$366,011,490 IONS, ARGX, NBIX, VRTX, ISRG 13F-HR 14 Feb 2024, 12:10
Q3 2023 154 $6,206,909,484 +$218,578,193 -$378,687,648 -$160,109,455 ARGX, IONS, VRTX, NBIX, ISRG 13F-HR 14 Nov 2023, 13:54
Q2 2023 156 $7,010,438,897 +$379,369,118 -$604,212,685 -$224,843,567 VRTX, IONS, ARGX, ISRG, NBIX 13F-HR 14 Aug 2023, 12:53
Q1 2023 159 $6,891,167,301 +$209,555,028 -$576,525,008 -$366,969,980 VRTX, IONS, ARGX, NBIX, ISRG 13F-HR 15 May 2023, 10:12
Q4 2022 171 $7,533,043,112 +$332,546,283 -$343,420,866 -$10,874,583 IONS, ARGX, NBIX, VRTX, MRNA 13F-HR 14 Feb 2023, 12:44
Q3 2022 176 $6,959,222,000 +$135,720,995 -$412,971,972 -$277,250,977 IONS, VRTX, ARGX, NBIX, ALNY 13F-HR 14 Nov 2022, 13:52
Q2 2022 172 $7,074,165,000 +$414,825,536 -$593,777,289 -$178,951,753 IONS, ARGX, VRTX, NBIX, MRNA 13F-HR 11 Aug 2022, 10:51
Q1 2022 177 $8,611,961,000 +$494,347,335 -$872,506,397 -$378,159,062 VRTX, IONS, ARGX, NBIX, MRNA 13F-HR 13 May 2022, 16:19
Q4 2021 191 $9,701,498,000 +$842,709,680 -$442,446,751 +$400,262,929 MRNA, VRTX, ARGX, IONS, NBIX 13F-HR 10 Feb 2022, 10:50
Q3 2021 219 $9,853,973,000 +$688,508,479 -$821,412,978 -$132,904,499 MRNA, VRTX, IONS, ARGX, NBIX 13F-HR 12 Nov 2021, 06:30
Q2 2021 213 $10,244,272,000 +$933,937,621 -$737,426,921 +$196,510,700 MRNA, IONS, VRTX, NBIX, ARGX 13F-HR 12 Aug 2021, 12:51
Q1 2021 216 $9,451,547,000 +$1,069,650,503 -$460,604,026 +$609,046,477 IONS, MRNA, NBIX, VRTX, ARGX 13F-HR 11 May 2021, 17:46
Q4 2020 222 $8,729,563,000 +$1,084,092,579 -$848,453,202 +$235,639,377 IONS, NBIX, MRNA, VRTX, ARGX 13F-HR 16 Feb 2021, 08:59
Q3 2020 217 $7,237,378,000 +$486,360,606 -$289,830,013 +$196,530,593 IONS, NBIX, INCY, VRTX, ARGX 13F-HR 16 Nov 2020, 16:23
Q2 2020 208 $7,065,908,000 +$580,137,760 -$519,533,379 +$60,604,381 IONS, NBIX, INCY, VRTX, ESPR 13F-HR 13 Aug 2020, 16:04
Q1 2020 214 $5,156,585,000 +$382,096,772 -$411,124,083 -$29,027,311 IONS, VRTX, NBIX, INCY, ALNY 13F-HR 14 May 2020, 14:32
Q4 2019 215 $6,307,393,000 +$582,592,619 -$591,071,830 -$8,479,211 IONS, NBIX, INCY, VRTX, ESPR 13F-HR 14 Feb 2020, 14:38
Q3 2019 210 $5,376,712,000 +$344,461,303 -$242,045,220 +$102,416,083 IONS, NBIX, INCY, VRTX, SAGE 13F-HR 14 Nov 2019, 16:57
Q2 2019 201 $5,856,751,000 +$4,188,326,599 -$161,805,141 +$4,026,521,458 IONS, INCY, NBIX, VRTX, SAGE 13F-HR 14 Aug 2019, 14:28
Q1 2019 134 $1,817,215,000 +$302,864,115 -$229,490,137 +$73,373,978 ALGN, ISRG, ABT, ILMN, TDOC 13F-HR 15 May 2019, 15:12
Q4 2018 138 $1,520,968,000 +$367,914,375 -$150,291,309 +$217,623,066 ILMN, ABT, ISRG, ALGN, ELV 13F-HR 12 Feb 2019, 17:17
Q3 2018 138 $1,576,423,000 +$286,840,470 -$53,854,704 +$232,985,766 ELV, ALGN, ABT, CELG, ILMN 13F-HR 13 Nov 2018, 12:32
Q2 2018 138 $1,172,986,000 +$195,640,165 -$117,098,026 +$78,542,139 ELV, ALGN, CELG, ISRG, ILMN 13F-HR 07 Aug 2018, 17:03
Q1 2018 124 $1,009,379,000 +$145,481,321 -$121,559,984 +$23,921,337 ALGN, ELV, CELG, ISRG, ABT 13F-HR 09 May 2018, 14:42
Q4 2017 134 $957,226,000 +$147,268,687 -$131,353,507 +$15,915,180 CELG, ELV, ALGN, ISRG, ILMN 13F-HR 14 Feb 2018, 15:48
Q3 2017 131 $956,149,000 +$159,316,419 -$72,990,498 +$86,325,921 CELG, AMGN, ALGN, GILD, ILMN 13F-HR 13 Nov 2017, 12:20
Q2 2017 132 $844,113,000 +$125,984,617 -$85,515,487 +$40,469,130 CELG, AMGN, MDT, UNH, ELV 13F-HR 14 Aug 2017, 13:23
Q1 2017 132 $750,418,000 +$243,170,559 -$34,058,656 +$209,111,903 CELG, AMGN, INCY, CNC, UNH 13F-HR 11 May 2017, 14:37
Q4 2016 122 $488,317,000 +$45,621,499 -$65,014,903 -$19,393,404 CELG, SYK, MDT, UNH, ABT 13F-HR 10 Feb 2017, 12:48
Q3 2016 121 $552,269,000 +$49,546,730 -$54,171,640 -$4,624,910 MDT, SYK, CELG, ILMN, BIIB 13F-HR 10 Nov 2016, 16:19
Q2 2016 124 $531,462,000 +$85,740,934 -$117,759,577 -$32,018,643 MDT, SYK, CELG, ABT, CAH 13F-HR 12 Aug 2016, 16:58
Q1 2016 130 $551,070,000 $0 $0 $0 GILD, CELG, MDT, BIIB, ABT 13F-HR 16 May 2016, 10:21